Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures
Status:
Terminated
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The aim of this clinical trail is to evaluate the efficacy of a Carbogen inhalation in
patients with febrile seizures compared to a placebo-inhalation.
Further aims are the evaluation of the safety of the Carbogen inhalation via a low-pressure
can with a breathing mask in a home-setting, the manageability of the Carbogen inhalation via
a low pressure can with a breathing mask in a home-setting or on the way (mobility), the
quality of life of the parents and children using the low pressure can with a breathing mask
in a home-setting or on the way (mobility) and the contentment and anxiety of the parents.